Management of Spontaneous Ear Bleeding in Elderly Patients

Immediate Assessment and Stabilization

The American College of Cardiology recommends immediately assessing for anticoagulant or antiplatelet use and obtaining urgent coagulation studies in elderly patients, as they present with significantly greater risk of life-threatening coagulopathic bleeding requiring emergent reversal 1, 2
A focused medication history should be obtained, specifically for warfarin, DOACs, antiplatelet agents, and NSAIDs, as elderly patients on anticoagulation have markedly increased bleeding risk and altered pharmacokinetics 3, 1
Hemodynamic stability should be assessed immediately, with monitoring activated if heart rate >90 bpm or systolic blood pressure <110 mmHg, due to blunted compensatory responses in elderly patients 4

A complete blood count (CBC) should be performed to assess for anemia and thrombocytopenia 2
A coagulation panel, including INR, aPTT, fibrinogen, and platelet count, must be obtained urgently 2
Arterial or venous blood gas for baseline base deficit or lactate assessment should be performed to evaluate for occult hypoperfusion, as lactate >2 mmol/L for >48 hours or base deficit <-6 mEq/L increases mortality risk four-fold in elderly patients 2, 4

For warfarin-associated bleeding, 4-factor prothrombin complex concentrate (4F-PCC) plus 5 mg IV vitamin K should be administered immediately, targeting INR <1.5 before any intervention 2, 4
For dabigatran-associated bleeding, idarucizumab 5 g IV should be administered immediately 2
For rivaroxaban/apixaban-associated bleeding, andexanet alfa should be administered per protocol 2

Serial base deficit and lactate measurements should be performed to assess for ongoing bleeding and resuscitation adequacy 2, 4
Serial hemoglobin/hematocrit measurements every 6-12 hours should be performed until bleeding is controlled and values stabilize 4
Nutritional assessment should be performed, as malnutrition worsens coagulopathy in elderly patients through reduced protein binding and altered drug metabolism 2, 6

Single hematocrit measurements should not be relied upon as an isolated marker for bleeding, as they may not reflect acute blood loss 1
Elderly patients are more prone to bleeding even after controlling for anticoagulation intensity, suggesting intrinsic age-related vascular changes contribute independently 6
The combination of anticoagulants with antiplatelet agents creates exponentially increased bleeding risk that may not be reflected in INR values alone 6